Epstein-Barr virus persistence and reactivation in neuromyelitis optica

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 86, Issue 10, 2015, Pages 1137-1142

  Masuda, Saeko ^a   Mori, Masahiro ^a   Arai, Kimihito ^b   Uzawa, Akiyuki ^a   Muto, Mayumi ^a   Uchida, Tomohiko ^a   Masuda, Hiroki ^a   Kuwabara, Satoshi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b SAKURA NATIONAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4 ANTIBODY; EARLY ANTIGEN IMMUNOGLOBULIN G ANTIBODY; EARLY ANTIGEN IMMUNOGLOBULIN M ANTIBODY; EPSTEIN BARR VIRUS ANTIGEN 1 IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS CAPSID ANTIGEN IMMUNOGLOBULIN G ANTIBODY; VIRUS CAPSID ANTIGEN IMMUNOGLOBULIN M ANTIBODY; IMMUNOGLOBULIN G; VIRUS ANTIGEN;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS INFECTION; FEMALE; HERPES SIMPLEX VIRUS; HUMAN; MALE; MULTIPLE SCLEROSIS; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; VARICELLA ZOSTER VIRUS; VIRUS REACTIVATION; VIRUS REPLICATION; EPSTEIN BARR VIRUS; GENETICS; IMMUNOLOGY; LONGITUDINAL STUDY; MYELOOPTIC NEUROPATHY; PHYSIOLOGY; VIROLOGY; VIRUS ACTIVATION;

ADULT; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN G; LONGITUDINAL STUDIES; MALE; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; VIRUS ACTIVATION;

EID: 84942308897     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2014-308095     Document Type: Article

References (28)

1. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: The role of infection. Ann Neurol 2007;61:288-99.
2. Pender MP. Does Epstein-Barr virus infection in the brain drive the development of multiple sclerosis? Brain 2009;132:3196-8.
3. Levin LI, Munger KL, O'Reilly EJ, et al. Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann Neurol 2010;67:824-30.
4. Koga M, Takahashi T, Kawai M, et al. A serological analysis of viral and bacterial infections associated with neuromyelitis optica. J Neurol Sci 2011;300:19-22.
5. Sellner J, Hemmer B, Mühlau M. The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes. J Autoimmun 2010;34:371-9.
6. Yoshimura S, Isobe N, Matsushita T, et al. Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status. J Neurol Neurosurg Psychiatry 2013;84:29-34.
7. Varrin-Doyer M, Spencer CM, Schulze-Topphoff U, et al. Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter. Ann Neurol 2012;72:53-64.
8. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485-9.
9. Mandler RN. Neuromyelitis optica - Devic's syndrome, update. Autoimmun Rev 2006;5:537-43.
10. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-7.
11. Reiber H, Lange P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem 1991;37:1153-60.
12. Reiber H. Cerebrospinal fluid--physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Mult Scler 1998;4:99-107.
13. Münz C, Lümemann JD, Getts MT, et al. Antiviral immune responses: triggers of or triggered by autoimmunity? Nat Rev Immunol 2009;9:246-58.
14. Inoue H, Mishima K, Yamamoto-Yoshida S, et al. Aryl hydrocarbon receptor-mediated induction of EBV reactivation as a risk factor for Sjögren's syndrome. J Immunol 2012;188:4654-62.
15. Ascherio A, Munger KL, Lennette ET, et al. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 2001;286:3083-8.
16. Sundström P, Juto P, Wadell G, et al. An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology 2004;62:2277-82.
17. Levin LI, Munger KL, Rubertone MV, et al. Temporal relationship between elevation of Epstein-Barr virus antibody titres and initial onset of neurological symptoms in multiple sclerosis. JAMA 2005;293:2496-500.
18. Castellazzi M, Tamborino C, Cani A, et al. Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis. Mult Scler 2010;16:883-7.
19. Sumaya CV. Endogenous reactivation of Epstein-Barr virus infections. J Infect Dis 1977;135:374-9.
20. Cohen JI, Jaffe ES, Dale JK, et al. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood 2011;117:5835-49.
21. Stewart JP, Rooney CM. The interleukin-10 homolog encoded by Epstein-Barr virus enhances the reactivation of virus-specific cytotoxic T cell and HLA-unrestricted killer cell responses. Virology 1992;191:773-82.
22. Uzawa A, Mori M, Arai K, et al. Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6. Mult Scler 2010;16:1443-52.
23. Chihara N, Aranami T, Sato W, et al. Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica. Proc Natl Acasd Sci USA 2011;10:3701-6.
24. Lassmann H, Niedobitek G, Aloisi F, et al. Epstein-Barr virus in the multiple sclerosis brain: a controversial issue - report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria. Brain 2011;134:2772-86.
25. Serafini B, Rosicarelli B, Franciotta D, et al. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 2007;204:2899-912.
26. Willis SN, Stadelmann C, Rodig SJ, et al. Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain 2009;132: 3318-28.
27. Peferoen LA, Lamers F, Lodder LN, et al. Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis. Brain 2010;133:1-4.
28. Myhr KM, Riise T, Barrett-Connor E, et al. Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway. J Neurol Neurosurg Psychiatry 1998;64:539-42.